Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2019

Primary Completion Date

May 25, 2022

Study Completion Date

September 1, 2022

Conditions
Prosthetic Joint InfectionVancomycinJoint Diseases
Interventions
DRUG

Experimental Intraosseous vancomycin 500mg in 250 mL NS

500mg of Vancomycin in 250 mL of normal saline will be injected into a pre-specified region of the greater trochanter during primary total hip arthroplasty.

DRUG

Standard IV administration of vancomycin

IV antibiotics (cefepime \& vancomycin) are started in pre-op approximately 1 hour prior to incision (vancomycin dose weight-based at approximately 15mg/kg, generally 1000-1750mg in 500 mL NS).

Trial Locations (1)

77030

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT04042233 - Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol | Biotech Hunter | Biotech Hunter